
Autolus Ltd.
London Work here? Claim profile
Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer
London Work here? Claim profile
Mission
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
Similar companies
View all